About Longevity Leaders

Longevity science & regenerative medicine

LSX are known for bringing life science investors together to assess and meet with the most promising up and coming biotech companies. A few years ago, one of our investors asked us to look into the emerging field of ageing science and the development of new drugs targeting ageing as a disease. And so, Longevity Leaders was born.

The conference has evolved over the years – not in the least with the virtual flip-flopping necessitated by a global pandemic – but in 2022 returns live in London! It is now one of the world’s most respected scientific events in the space, presenting responsible ageing science and the development of drugs in a new paradigm of disease prevention.

Longevity science is at a critical moment in time. In the wake of the COVID-19 pandemic, investors, regulators and the medical community have woken up to the promise of ageing science and its potential to completely change how we prevent and treat disease. Advanced analytical tools are driving huge strides in our understanding of ageing biology and potential targets, and a number of high-profile fund raises are driving investor interest in the space. With that in mind, we’re more excited than ever to be bringing the community back together, face-to-face, for our fourth annual Longevity Leaders World Congress.

At the same time, regenerative medicine is going from strength-to-strength and has an important role to play in longevity. For the first time, cell therapies, gene therapies, bioaesthetic treatments, tissue engineering and enabling technologies will be presented at the conference in a brand new Regenerative Medicine track.

So, if you’re passionate about all things ageing science do join us, and more than 200 biotech, pharmaceutical, investment, regulatory and scientific professionals at Longevity Leaders World Congress 2022. You’ll hear the latest developments in ageing biology, get clinical updates from the companies at the industry forefront and source the services partners who are helping to deliver on this new paradigm of disease prevention.

Key contacts